Therapeutic effects of hydrogen on chronic graft-versus-host disease.
In mice, figure 1 Administration of hydrogen‐rich saline intraperitoneally from the 20th day after transplantation protects mice from cGVHD ( n = 30, P < 0.05). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways…
Read Article